Clinical Trial Update: The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant Gliomas

View source ↗

Summary

This document reports an update on using APT MRI to predict Bevacizumab efficacy in patients with recurrent malignant gliomas; the trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma
• Oligodendroglioma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Zhujiang Hospital | Conditions: Diagnoses Disease, Glioma of Brain | Status: UNKNOWN